Metsera

The $10 Billion Gamble: Pfizer's Bold Leap into the Weight-Loss Frontier

The Watchdogs Are Barking: Why Metsera's Big Deal Just Hit a Snag

The Billion-Dollar Beatdown: How Novo Nordisk Clinched Metsera in a High-Stakes Pharma Showdown

Caught in the Crossfire: Pfizer Accuses Novo Nordisk of Sabotaging a Critical Biotech Merger

The Billion-Dollar Standoff: Pfizer Takes On Novo Nordisk for a Slice of the Future

The Weight-Loss Gold Rush: Why All Eyes Are On Viking Therapeutics After a Hefty Biotech Deal

The Billion-Dollar Standoff: Pfizer Unleashes on Novo Nordisk in Metsera Bid Battle

The Great Weigh-In: Pharma's Fierce Battle for the Future of Obesity, and What Else Keeps Them Up at Night

Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s

Pfizer's Bold Gambit: Unleashing New Weapons in the Global Battle Against Obesity

Metsera: The New Power Player Set to Disrupt the $100 Billion GLP-1 Market